See how convenient it can be for your patients to start treatment with INGREZZA


The only VMAT2 inhibitor that offers the ease of one capsule, once daily

VMAT2, vesicular monoamine transporter 2.


Two dosing options that work


Not actual size.

  • Initial dosage of INGREZZA® (valbenazine) capsules is 40 mg once daily for one week1,2
  • After the first week, 80 mg is recommended once
    daily, but remaining on 40 mg may be considered
    for some patients1-3
    • Once on INGREZZA 80 mg, adjusting back to 40 mg may be considered based on your patient’s individual
      treatment needs1,2
    • In clinical trials, investigators could decrease the 80 mg dose once at any time during the study due to
      tolerability; participants were discontinued if the new dose was not tolerated1,2

INGREZZA can be taken with or without food.1

In clinical trials, patients receiving
INGREZZA were allowed to remain on their stable treatment
regimen, including antipsychotics.1

REFERENCES: 1. INGREZZA [package insert]. San Diego, CA: Neurocrine Biosciences, Inc; 2020. 2. Hauser RA, Factor SA, Marder SR, et al. KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry. 2017;174(5):476-484. 3. Data on file. Neurocrine Biosciences, Inc.